Altria Group (MO) is back in focus after reporting Q1 2026 results that topped market expectations on both earnings and revenue, supported by Marlboro and on! nicotine pouches, and by maintaining full year guidance.

The Q1 beat has been followed by a sharp move in the share price, with a 1 day share price return of 6.52%, adding to a 26.77% year to date share price return and a 31.11% 1 year total shareholder return. These returns point to building momentum rather than a short lived spike.

If you are looking beyond tobacco for what is moving in markets right now, this is a good moment to broaden your search and check out 17 top founder-led companies

With Q1 beating expectations, guidance intact and the share price already up strongly, the key question now is whether Altria still trades at a discount or if the recent rally means the market is already pricing in future growth?

Most Popular Narrative: 10.9% Overvalued

At a last close of $72.65 against a most followed fair value estimate of $65.50, the prevailing narrative sees Altria trading above its calculated worth while still leaning on long established earnings drivers.

The analysts have a consensus price target of $65.5 for Altria Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $74.0, and the most bearish reporting a price target of just $50.0.

Want to see what keeps earnings steady even while revenue expectations are flat? The narrative leans heavily on richer margins, disciplined share count, and a future profit multiple that has to compress to make the numbers work.

Result: Fair Value of $65.50 (OVERVALUED)

However, tighter regulation of e-vapor and nicotine pouches, or prolonged legal and antitrust actions around Juul and NJOY, could challenge the current overvaluation story.

Another Angle On Value: P/E Says Undervalued

The narrative prices Altria at about 10.9% above a $65.50 fair value, yet our P/E work points the other way. At $72.65, Altria trades on 17.5x earnings versus a 20.1x fair ratio and 19.5x for peers, while the global tobacco group sits nearer 12.9x. That mix suggests either a cushion if the market leans toward the higher fair ratio, or less upside if investors focus on the cheaper global sector. Which reference point matters more to you?

Next Steps

Given the mix of optimism and caution running through this story, it makes sense to look at the data yourself, decide quickly where you stand, and then weigh the 1 key reward and 5 important warning signs

Ready to uncover more investment ideas?

If Altria has caught your attention, do not stop here. Use this momentum to size up a wider set of opportunities that fit your goals.

• Target stability with income by checking out 12 dividend fortresses that focus on companies offering higher yields with robust dividend profiles.
• Hunt for quality at a sensible price through 51 high quality undervalued stocks highlighting businesses that pair solid fundamentals with valuations that may look appealing.
• Prioritise resilience by scanning 74 resilient stocks with low risk scores featuring companies that score well on financial strength and lower overall risk.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.